Thymosin Alpha-1 (Tα1) is a synthetic version of a naturally occurring peptide produced by the thymus gland. It is a potent immune modulator that enhances the body's immune response against infections and helps regulate the immune system in cases of autoimmunity.
Key points
Thymosin Alpha-1 acts primarily through the Toll-like receptors (TLRs), specifically TLR9, to stimulate the production of cytokines and enhance the activity of various immune cells. It promotes the maturation of T-lymphocytes and restores the balance of Th1/Th2 immune responses [1:1][4].
Goldstein, A. L., et al. (2015). Thymosins: Chemistry, Biology, and Clinical Applications. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.12851 ↩︎ ↩︎
Matteucci, C., et al. (2017). Thymosin alpha 1 and Cancer: Action on Immune System and Directly on Cancer Cells. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2017.1360211 ↩︎
King, R., & Tuthill, C. (2016). Thymosin Alpha 1: A Comprehensive Review of its Safety and Efficacy. Journal of Peptide Science. https://doi.org/10.1002/psc.2891 ↩︎
Serafino, A., et al. (2014). Thymosin α1: A Protective Peptide in the Immune System. Current Pharmaceutical Design. https://doi.org/10.2174/13816128113199990425 ↩︎